Table 2 Weight gain, total food intake, serum inflammation and oxidative stress biomarkers, and antioxidant enzyme activity in liver at the end of the prevention phase

Weight gain (g)

94 ± 19.1^a

142.8 ± 26^b

116.1 ± 16.2^a

Food Intake (g)

152.4 ± 13.9^a

175.8 ± 12.3^b

159.9 ± 8.7^a

CCK (ng/l)

139.1 (103–187.5)

155.6 (128.5–216.5)

124 (114.9–133.1)

hs_CRP(ng/ml)

3 ± 0.5^a

4.1 ± 0.7^b

3.2 ± 0.5^a

PTX-3 (ng/ml)

0.66 ± 0.09^a

0.84 ± 0.09^b

0.68 ± 0.11^a

MMP-9 (ng/ml)

0.65 ± 0.1

0.74 ± 0.1

0.62 ± 0.1

TAC (μmol/l)

227.8 ± 26.9

220.3 ± 16.7

216.6 ± 22.3

GPX (U/ml)

228.3 ± 54.2

220.8 ± 38.8

288 ± 85

SOD (U/ml)

54 ± 20.7^ab

37.8 ± 14.3^a

65.9 ± 9.4^b

Steatosis score

0(0–0.25)^a

2(1–2)^b

1(0–1)^a

NAS score

0.5 ± 0.83^a

3.83 ± 1.16^b

2 ± 1.09^c